I must admit that when I read a report about the recall of breast cancer drug Albupax for the presence of more-than-permissible levels of endotoxins I was moved to wonder aloud how such a product could have been approved in the first place. (See my tweet). Well, I may have overreacted. From what I gather, there's more … Continue reading Another nano controversy
Apothecurry 